Welcome to ASCO Connection Discussion

The ASCO Connection Discussion forum is a space for oncology professionals and others with an interest in cancer care to ask and answer questions about every aspect of the field, from professional development advice to clinical conundrums. Everyone is welcome to participate: to ask a question or leave a response, first log in with your ASCO username and password. Please read the Discussion and Commenting Guidelines before you post a question or response. Contact our staff by email for assistance with the Discussion forum.

Our goal is to facilitate communication and create collaborative opportunities among oncology health care professionals of various disciplines in the Arab World Region to enhance their professional development and improve cancer care in the region. All health care professionals with an interest in...

Read more to answer the following questions:
1. Who should get routine molecular testing at the time of diagnosis of NSCLC and what genes should be included in the molecular panel?
2. What is the proper timing of testing and sequencing of available therapies?
3. What treatment options are available...

In 2015, ASCO partnered with local organizers to hold Multidisciplinary Cancer Management Courses (MCMCs) in Brazil, Zimbabwe, and China. One year later, follow-up surveys were sent to participants to assess the impact the course had on their practices.
The first MCMC was held in São Paulo, Brazil...

Read more to answer the following questions:
1. Recognize the diagnosis of CML and importance of bone marrow biopsy at presentation.
2. Apply considerations when choosing initial therapy.
3. Recognize when to switch therapy when response is suboptimal.
4. Identify how to treat...